Press Release
Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR
May 23, 2023
Read More at Our Investor Site
Because we’re making headlines
We do it by making a difference in the lives of our patients. Stay current with the latest news, information and events at Lantheus. Please visit our investor site for a complete list of recent and archived press releases. Follow us on LinkedIn for social media updates.
For media resources, including images, logos, videos, and more, browse our media library.
Latest Press Releases
Press Release
Lantheus Reports First Quarter 2023 Financial Results
May 4, 2023
Read More at Our Investor SitePress Release
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
April 24, 2023
Read More at Our Investor Site
